skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Navigating the issues presented by biosimilars is becoming more complicated. With new barriers facing biosimilar originator companies and threatening to derail development, knowing how to formulate and manage your own biosimilar action plan is critically important.

Explore the components essential for understanding how biosimilar originator companies are responding to threats to their profit margins with this webinar recording from Informa Pharma Intelligence.

Experts from Scrip, part of the Informa Pharma Intelligence suite of tools, used data from across Pharma Intelligence to present vital information about the issues facing the biosimilars market and what they might mean for the future.

Listen to the recording now, where Scrip experts will be:

  • Analyzing the exposure of key originator companies to biosimilar competition
  • Considering the different tactics that originators are using in the face of biosimilar competition
  • Examining the situation across global markets, including the regulatory environments
  • Reviewing the first Humira biosimilars to launch in Europe
  • Exploring how the first US biosimilars are trending and the challenging commercial dynamics
  • Providing insights into likely future developments and trends
  •  

    The slides are available to download here


    おすすめのニュース&レポート

    ;

    お問い合わせ&レポートストア

    専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

    *一部のサービスでは無料トライアルをご利用になれません。

    ご質問等ございましたらお気軽にご連絡下さい。

    日本(平日:9時~18時)
    電話:+81 (0)3 6273 4260
    Email:inquiry.jp@informa.com

    オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

    お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。